Source and scope
This summary is bounded to the recommendations, population and decisions covered by Guideline No. 397: Conservative Care of Urinary Incontinence in Women. Apply it with the current provincial or territorial pathway where implementation differs.
sources for this section:SOGC 397
Source-attributed clinical priorities
- Classify stress, urgency, mixed, overflow and functional contributors and assess prolapse, retention, infection and hematuria.
- Begin pelvic-floor, bladder, fluid and contributing-medication interventions matched to the phenotype.
- Discuss pessary, medication and surgery through shared decisions, referring pain, bleeding, obstruction or complex recurrence.
- Determine whether leakage is stress, urgency, overflow, functional or mixed before choosing treatment.
sources for this section:SOGC 397
Practical assessment and management workflow
1
Record bladder diary, fluid and caffeine, bowel function, births, pelvic symptoms, medicines and neurologic features.
2
Examine abdomen and pelvis with consent and measure urinalysis and residual urine when indicated.
3
Begin pelvic-floor, bladder training and reversible-contributor care matched to the phenotype.
4
Review response and discuss pessary, medication or surgical referral around goals and risks.
sources for this section:SOGC 397
Safety, red flags and urgent escalation
- Acute retention, hematuria, recurrent infection, hydronephrosis or major neurologic change needs urgent assessment.
- Check anticholinergic cognitive and retention risk before bladder medicine.
- Ulcerated, incarcerated or obstructive prolapse requires prompt gynecologic evaluation.
sources for this section:SOGC 397
Confirm the local pathway before acting
The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.
sources for this section:SOGC 397
Source and implementation boundary
Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:SOGC 397
Source documents
Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.
- Society of Obstetricians and Gynaecologists of CanadaGuideline No. 397: Conservative Care of Urinary Incontinence in Womenaccessed 2026-08-20view source
continue the learning
From guidance to deliberate practice and evidence
Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.
Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Canada question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.